Should patient setup in lung cancer be based on the primary tumor? An analysis of tumor coverage and normal tissue dose using repeated positron emission tomography/computed tomography imaging.
暂无分享,去创建一个
Philippe Lambin | Wouter van Elmpt | Dirk De Ruysscher | Michel Öllers | P. Lambin | W. V. van Elmpt | D. de Ruysscher | M. Öllers | W. van Elmpt
[1] Philippe Lambin,et al. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study. , 2005, International journal of radiation oncology, biology, physics.
[2] P. Lambin,et al. Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study. , 2010, International journal of radiation oncology, biology, physics.
[3] P. Lambin,et al. Volume or position changes of primary lung tumor during (chemo-)radiotherapy cannot be used as a surrogate for mediastinal lymph node changes: the case for optimal mediastinal lymph node imaging during radiotherapy. , 2011, International journal of radiation oncology, biology, physics.
[4] J C Stroom,et al. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. , 1999, International journal of radiation oncology, biology, physics.
[5] Jan J W Lagendijk,et al. MRI/linac integration. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[6] John Wong,et al. Quantification of tumor volume changes during radiotherapy for non-small-cell lung cancer. , 2009, International journal of radiation oncology, biology, physics.
[7] P. Lambin,et al. Individualized radical radiotherapy of non-small-cell lung cancer based on normal tissue dose constraints: a feasibility study. , 2008, International journal of radiation oncology, biology, physics.
[8] Agung Hertanto,et al. Observation of interfractional variations in lung tumor position using respiratory gated and ungated megavoltage cone-beam computed tomography. , 2007, International journal of radiation oncology, biology, physics.
[9] Philippe Lambin,et al. PET-CT-based auto-contouring in non-small-cell lung cancer correlates with pathology and reduces interobserver variability in the delineation of the primary tumor and involved nodal volumes. , 2007, International journal of radiation oncology, biology, physics.
[10] M. V. van Herk,et al. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[11] Patrick A Kupelian,et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. , 2005, International journal of radiation oncology, biology, physics.
[12] Philippe Lambin,et al. Intra-patient variability of tumor volume and tumor motion during conventionally fractionated radiotherapy for locally advanced non-small-cell lung cancer: a prospective clinical study. , 2006, International journal of radiation oncology, biology, physics.
[13] Wolfgang A Tomé,et al. Tumor volume changes on serial imaging with megavoltage CT for non-small-cell lung cancer during intensity-modulated radiotherapy: how reliable, consistent, and meaningful is the effect? , 2006, International journal of radiation oncology, biology, physics.
[14] Marcel van Herk,et al. Different styles of image-guided radiotherapy. , 2007 .
[15] Marcel van Herk,et al. Reduction of observer variation using matched CT-PET for lung cancer delineation: a three-dimensional analysis. , 2006, International Journal of Radiation Oncology, Biology, Physics.
[16] Jan-Jakob Sonke,et al. Variability of four-dimensional computed tomography patient models. , 2008, International journal of radiation oncology, biology, physics.
[17] Philippe Lambin,et al. Mature results of an individualized radiation dose prescription study based on normal tissue constraints in stages I to III non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[18] Suresh Senan,et al. Motion analysis of 100 mediastinal lymph nodes: potential pitfalls in treatment planning and adaptive strategies. , 2008, International journal of radiation oncology, biology, physics.
[19] Suresh Senan,et al. Time trends in target volumes for stage I non-small-cell lung cancer after stereotactic radiotherapy. , 2006, International journal of radiation oncology, biology, physics.
[20] P. Lambin,et al. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial. , 2008, International journal of radiation oncology, biology, physics.
[21] P. Lambin,et al. Time trends in nodal volumes and motion during radiotherapy for patients with stage III non-small-cell lung cancer. , 2007, International journal of radiation oncology, biology, physics.
[22] Jan-Jakob Sonke,et al. Adaptive radiotherapy for lung cancer. , 2010, Seminars in radiation oncology.
[23] J. Lebesque,et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. , 2006, International journal of radiation oncology, biology, physics.